ANNUAL RESULTS
AstraZeneca Pharma India Ltd.
BSE
Jun 19, 04:01
9422.95
-311.70 ( -3.20%)
Volume
4381
Prev. Close
9734.65
Open Price
9599.85
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 19, 03:59
9410.50
-324.00 ( -3.33%)
Volume
40260
Prev. Close
9734.50
Open Price
9680.50
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
9410.50 (55)
You can view the
Annual Results
for the last 5 years.
|
ISIN No
|
INE203A01020
|
Market Cap. ( ₹ in Cr. )
|
23526.25
|
P/BV
|
34.63
|
Book Value ( ₹ )
|
271.74
|
|
BSE Code
|
506820
|
52 Week High/Low ( ₹ )
|
10691/6070
|
FV/ML
|
2/1
|
P/E(X)
|
203.27
|
|
NSE Code
|
ASTRAZENEQ
|
Book Closure
|
05/07/2024
|
EPS ( ₹ )
|
46.30
|
Div Yield (%)
|
0.34
|
(₹ in Crs.)
| Net Sales/Income from operations | 1716.29 | 1295.53 | 1002.97 | 805.60 | 813.56 |
| Total Income From Operations | 1716.29 | 1295.53 | 1002.97 | 805.60 | 813.56 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 287.13 | 129.02 | 84.38 | 89.61 | 97.26 |
| Purchase of Traded Goods | 1008.82 | 499.31 | 324.46 | 207.88 | 194.74 |
| Increase/Decrease in Stocks | -332.94 | -33.77 | -48.86 | 14.47 | 2.95 |
| Employees Cost | 257.44 | 241.45 | 259.10 | 230.21 | 219.54 |
| Depreciation | 39.99 | 14.94 | 16.26 | 16.95 | 20.13 |
| Admin. And Selling Expenses | 84.87 | 0.00 | 0.00 | 0.00 | 45.21 |
| Other Expenses | 157.00 | 275.07 | 218.77 | 177.26 | 118.39 |
| Total Expenses | 1502.31 | 1126.02 | 854.11 | 736.37 | 698.22 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 213.98 | 169.51 | 148.87 | 69.23 | 115.35 |
| Other Income | 40.63 | 34.80 | 26.10 | 14.76 | 12.84 |
| P/L Before Interest, Excpt. Items & Tax | 254.61 | 204.31 | 174.97 | 83.98 | 128.19 |
| Interest | 1.46 | 1.20 | 0.63 | 0.95 | 1.09 |
| P/L Before Exceptional Items & Tax | 253.15 | 203.11 | 174.33 | 83.04 | 127.09 |
| Exceptional Items | -96.79 | 16.43 | -40.23 | 0.00 | 0.00 |
| P/L Before Tax | 156.36 | 219.54 | 134.10 | 83.04 | 127.09 |
| Tax | 40.62 | 58.03 | 34.81 | 21.44 | 33.79 |
| P/L After Tax from Ordinary Activities | 115.74 | 161.51 | 99.29 | 61.59 | 93.30 |
| Net Profit/Loss For the Period | 115.74 | 161.51 | 99.29 | 61.59 | 93.30 |
| | | | | | |
| Equity Share Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Reserves And Surplus | 765.35 | 706.92 | 583.69 | 506.39 | 451.17 |
| Equity Dividend Rate | 1600.00 | 1200.00 | 800.00 | 500.00 | 100.00 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 46.30 | 64.60 | 39.72 | 24.64 | 37.32 |
| Diluted EPS (Rs.) | 46.30 | 64.60 | 39.72 | 24.64 | 37.32 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 46.30 | 64.60 | 39.72 | 24.64 | 37.32 |
| Diluted EPS (Rs.) | 46.30 | 64.60 | 39.72 | 24.64 | 37.32 |
| | | | | | |
| PBITOE Margin (%) | 12.46 | 13.08 | 14.84 | 8.59 | 14.17 |
| PBTE Margin (%) | 14.74 | 15.67 | 17.38 | 10.30 | 15.62 |
| PBT Margin (%) | 9.11 | 16.94 | 13.37 | 10.30 | 15.62 |
| PAT Margin (%) | 6.74 | 12.46 | 9.89 | 7.64 | 11.46 |